165 related articles for article (PubMed ID: 1888308)
1. [Effect of ticlopidine and dipyridamole on platelet aggregation and count in patients with chronic stable angina pectoris].
Ramires JA; Mansur Ade P; Martins JR; Raineri A; Cesar LA; Bellotti G; Chamone DF; Pileggi F
Arq Bras Cardiol; 1991 Apr; 56(4):323-7. PubMed ID: 1888308
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of antiplatelet drugs on platelet functions--comparison between ticlopidine and dipyridamole after prosthetic valve replacement].
Saitoh H; Matsumoto H; Takayama T; Ide H; Miyawaki F; Furuse A
Kokyu To Junkan; 1989 Jan; 37(1):87-92. PubMed ID: 2734499
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation behaviour in patients treated with ticlopidine.
Petronio AS; Evangelisti L; Preti R; Gherarducci G; Balbarini A; Giordani R; Mariani M
Drugs Exp Clin Res; 1987; 13(1):43-50. PubMed ID: 3595443
[TBL] [Abstract][Full Text] [Related]
5. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.
Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F
J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
David JL; Limet R
Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
[TBL] [Abstract][Full Text] [Related]
10. Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.
Kastrati A; von Beckerath N; Joost A; Pogatsa-Murray G; Gorchakova O; Schömig A
Circulation; 2004 Oct; 110(14):1916-9. PubMed ID: 15262828
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
Saha S; Berglund M; Sylvén C; Gordon A; Agewall S
Int J Cardiol; 2008 Jan; 123(2):195-6. PubMed ID: 17320208
[TBL] [Abstract][Full Text] [Related]
12. Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel.
Lordkipanidzé M; Pharand C; Palisaitis DA; Schampaert E; Diodati JG
Thromb Res; 2009 Nov; 124(5):546-53. PubMed ID: 19419755
[TBL] [Abstract][Full Text] [Related]
13. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
14. [The effects of ticlopidine and nifedipine on platelet aggregation in patients with obliterating arteriopathy of the lower limbs].
Hevia Alonso A; Gago Angelino J; López-Valpuesta FJ; Serrano Molina JS; Fernández-Sanz S
Rev Clin Esp; 1992 Apr; 190(6):295-8. PubMed ID: 1598427
[TBL] [Abstract][Full Text] [Related]
15. [Blood platelet aggregation inhibitors in the treatment of heart diseases].
Verheugt FW
Ned Tijdschr Geneeskd; 1993 Aug; 137(33):1647-50. PubMed ID: 8371794
[No Abstract] [Full Text] [Related]
16. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
[TBL] [Abstract][Full Text] [Related]
18. [Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA; Savenkov MP
Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
[TBL] [Abstract][Full Text] [Related]
20. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
